These apps, some of which use AI and computer vision, were helpful for meeting my caloric and nutrition intake goals. But ...

As carrier filtering tightens and 10DLC throughput limits frustrate enterprise senders, Tells.co reports surge in ...

A new study suggests that almost half of people stopping GLP-1 weight-loss drugs may keep the weight off. However, many of these people continued other forms of treatment after stopping GLP-1 drugs.

Hyderabad: India's market for diabetes and weight-loss drugs is set for a shake-up as Danish drugmaker Novo Nordisk's patent on semaglutide expires ​this week, triggering a wave of cheaper ...

Mike White says he lost 15 pounds in nine days on Survivor 50, revealing how harsh conditions and his vegan diet left him ...

The cost of the popular weight loss drugs is pushing up premiums for city employees. The city and its unions should work out a deal to limit, but not end, coverage.

GIP obesity drug enters Phase 3 with strong cash runway, but rising competition and trial risk. Click for this VKTX update.

About 10 weeks after it was approved, the Wegovy pill is now estimated to be part of the daily regimen of about 400,000 Americans. And the field of weight-loss treatment is on the verge of even more ...

By Rishika Sadam HYDERABAD, March 19 (Reuters) - India's market for diabetes and weight-loss drugs is set for a shake-up as ...

For years, people with prediabetes have been told the same thing: lose weight or risk developing diabetes. But new research flips that idea on its head, showing that blood sugar can return to normal ...

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster ...

In addition to their weight loss benefits, GLP-1 RAs also act on neural circuits involved in appetite, impulse control, and ...